think it needs a break. phase 3 trial is going to take a long while, and phase 3 probabilities are not high for biotechs in general. theres much higher standard in phase 3. not that this wont be successful, but still a lot of risk from a 1 drug stock.
think it needs a break. phase 3 trial is going to take a long...
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
23.5¢ |
Change
-0.030(11.3%) |
Mkt cap ! $84.05M | |||
| Open | High | Low | Value | Volume |
| 26.5¢ | 26.5¢ | 23.0¢ | $295.6K | 1.206M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 292603 | 23.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.0¢ | 34773 | 4 |
View Market Depth
| Last trade - 11.09am 21/10/2024 (20 minute delay) ? |
| PAR (ASX) Chart |